The Palliative Care in Oncology Market is witnessing a steady rise due to increasing cancer cases as well as a greater emphasis on enhancing the quality of life of patients receiving treatment. Through the management of symptoms such as pain, nausea, fatigue, and psychological distress associated with cancer, palliative care also serves as a source of support for patients during their entire disease cycle. Among the factors propelling the market are the rise in the use of palliative care at an early stage, improvements in the management of pain and therapies for supportive care, and the growth of home-based care services.
Palliative Care in Oncology Market Trends & Forecast
According to a research study published by Knowledge Sourcing Intelligence (KSI), the palliative care in oncology market will expand from USD 165.2 billion in 2026 to USD 244.1 billion in 2031 at a CAGR of 8.1% during the forecast period.
The Palliative Care in Oncology Market is witnessing a strong growth driven by the rising worldwide cancer burden, enhanced awareness about the need to improve patients' quality of life, as well as the increasing adoption of palliative care as a part of the typical oncology treatments. Palliative care aims at easing pain, controlling symptoms caused by therapies, tackling patients' mental and emotional suffering, and offering supportive care throughout the patient's cancer journey. The growing incidence of late-stage cancer cases, in addition to an elderly population that is more vulnerable to cancer, has resulted in a higher need for extensive palliative care services and treatment options.
Request a free sample copy or view the report summary: Palliative Care in Oncology Market Report
Palliative Care in Oncology Market Report Highlights
It is expected that Pain Management will be the fastest-growing therapy-type segment in the Palliative Care in Oncology market since pain from cancer is very common among patients undergoing treatment, as well as those in the advanced stages of the disease. Alleviating pain is a fundamental goal of palliative care. Therefore, it has resulted in more use of pain relievers, various types of pain management programs, and customized treatment methods.
In the treatment of moderate-to-severe cancer pain, opioid analgesics will likely experience a great demand due to their high effectiveness. The increase in new cancer cases, the growing need for symptom management, and the continuous introduction of extended-release and abuse-deterrent formulations are some of the major drivers for the growth in this segment.
Lung cancer is expected to see the fastest growth in the indication segment because of its large disease burden worldwide and the significant symptoms caused by this condition. Those with advanced lung cancer often need palliative treatments aimed at relieving pain, breathlessness, fatigue, and psychological distress. Rising lung cancer cases, along with the broader use of palliative care in cancer treatment, are driving the need for supportive care services and drugs.
Oral administration is anticipated to be the most rapidly progressing segment in the market due to its multiple advantages, such as convenience, simplicity, and being a suitable option for long-term management of symptoms. The presence of a broad assortment of oral pain-killing, anti-nausea, and other supportive drugs is among the factors most stimulating the oncology palliative care market capacity of this route of administration.
Online Pharmacies are anticipated to become the fastest-growing channel of distribution primarily because of the enhanced digitalization in healthcare services and the higher consumer inclination towards a convenient way of buying medications. Patients undergoing treatment for cancer and their caregivers are gradually turning to online pharmacies for prescription drugs, care products, and home delivery services.
Palliative Care in Oncology Market Growth Drivers and Restraints
Growth Drivers:
Rising Global Cancer Burden: Cancer being one of the leading causes of death worldwide, the rise in the number of cancer patients has increased the need for symptom management and supportive care services. Palliative care is crucial in enhancing the quality of life of patients with late-stage and chronic cancers.
Growing Adoption of Early Palliative Care: More healthcare providers are adding palliative care to cancer treatment to raise patient outcomes. Starting care early can greatly help in pain reduction, treatment side effects, and psychological distress.
Restraints:
Shortage of Specialized Palliative Care Professionals: Many regions face a shortage of trained palliative care physicians, nurses, and counselors. This limits access to comprehensive supportive care services, particularly in rural and underserved areas.
Palliative Care in Oncology Market Key Development
Collaboration: In October 2025, Neyyar Medicity, together with Pallium India, launched the Comprehensive Palliative Care Program (CPCP). This event is a meaningful advancement of palliative healthcare into normal medical practice to provide patients and their families with medical treatment as well as complete healthcare that includes treatment of the physical, emotional, and psychosocial needs of the patient.
Collaboration: In October 2025, CanSupport, India’s leading provider of free palliative care, in partnership with Optum India, unveiled two mobile palliative care clinics (MPCCs) from Optum’s Gurgaon office.
Palliative Care in Oncology Market Segmentation
Knowledge Sourcing Intelligence has segmented the palliative care in oncology market based on drug class, therapy type, indication, route of administration, end user, distribution channel, and region:
Palliative Care in Oncology Market, By Therapy Type
Pain Management
Antiemetic Therapy
Nutritional Support
Psychological Support
Palliative Care in Oncology Market, By Drug Class
Opioid Analgesics
Non-Opioid Analgesics
5-HT3 Receptor Antagonists
NK1 Receptor Antagonists
Corticosteroids
Palliative Care in Oncology Market, By Indication
Lung Cancer
Breast Cancer
Colorectal Cancer
Pancreatic Cancer
Prostate Cancer
Palliative Care in Oncology Market, By Route of Administration
Oral
Intravenous
Transdermal
Subcutaneous
Palliative Care in Oncology Market, By End User
Hospitals
Hospice Care Centers
Home Care Settings
Cancer Specialty Clinics
Palliative Care in Oncology Market, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Palliative Care in Oncology Market, By Region
United States
Canada
Germany
United Kingdom
France
Italy
Spain
China
Japan
India
South Korea
Australia
Brazil
Mexico
Saudi Arabia
South Africa
Palliative Care in Oncology Market Key Players
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Novartis AG
Merck & Co., Inc.
GlaxoSmithKline plc
Mylan N.V. (Viatris)
Hikma Pharmaceuticals PLC
Johnson & Johnson
Sanofi
Baxter International Inc.
Have questions?
More Press Releases
Modular AI Data Center Infrastructure Market to Reach USD 8.71 Billion by 2032, Driven by Rapid Deployment of Prefabricated AI Data Centers
The global modular AI data center infrastructure market is expanding as demand for high-density computing and faster AI infrastructure deployment increases. Prefabricated power modules, integrated cooling systems, and turnkey AI factory solutions are gaining traction among hyperscale operators and neocloud providers seeking scalable, energy-efficient infrastructure to support increasingly complex AI workloads.
Autonomous Vehicle Interior Market to Reach USD 26.53 Billion by 2031, Driven by AI-Powered Smart Cockpits and Human-Machine Interfaces
The global autonomous vehicle interior market is expanding as AI-powered smart cockpits, advanced human-machine interfaces, and occupant monitoring technologies transform in-vehicle experiences. Growing adoption of software-defined vehicle architectures, connected infotainment, and personalized cabin systems is creating opportunities for automotive suppliers as higher-level vehicle automation advances across global markets.
Data Center Silicon Photonics Market to Reach USD 23.1 Billion by 2032, Driven by AI Infrastructure and Co-Packaged Optics Adoption
The global data center silicon photonics market is expanding as AI infrastructure, hyperscale computing, and high-bandwidth networking increase demand for advanced optical connectivity. Innovations in co-packaged optics, photonic integrated circuits, and energy-efficient interconnects are creating growth opportunities, while manufacturing scalability, thermal management, and integration costs remain important industry considerations.
